Cantor Fitzgerald Comments on BBIO FY2026 Earnings
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) – Research analysts at Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for BridgeBio Pharma in a report issued on Monday, June 9th. Cantor Fitzgerald analyst J. Schimmer forecasts that the company will post earnings of ($3.32) per share for the year. Cantor Fitzgerald has a […]
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) – Research analysts at Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for BridgeBio Pharma in a report issued on Monday, June 9th. Cantor Fitzgerald analyst J. Schimmer forecasts that the company will post earnings of ($3.32) per share for the year. Cantor Fitzgerald has a […]
